blue cross blue shield glp-1 coverage 2025 Major insurance changes are coming to drugs for weight loss. Here's how that could affect patients Insurance Coverage Changes for GLP-1

Most notably, muscle loss which may be related to reduced nutritional intake has become an important issue in the long-term management of patients undergoing GLP-1 therapy

The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage

Compared to traditional injectable GLP-1 drugs, HS-10535's oral administration significantly improves patient adherence, which is crucial for enhancing the quality of life for diabetes patients

There was also an association with pre-operative gastrointestinal symptoms (e.g., nausea, vomiting, abdominal pain, bloating) and the degree of residual gastric contents

Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease

Candy and chips makers may face narrower future paths to growth